QUOTED. Nov. 23, 2017. Scott Whitaker.
Check out what AdvaMed CEO Scott Whitaker had to say about the efforts by the US Congress to repeal the device tax (hint: he's not happy).
"I feel very good about the strategy [AdvaMed has] in place on getting the device tax fully repealed. What I don’t feel as good about is the urgency that we have is not reflected by those in Congress who need to pass it right now." – Scott Whitaker, CEO, AdvaMed
Click here for a free trial of Medtech Insight